Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Denis Bonnet"'
Autor:
Deanna L. Kelly, Jennifer R. Schroeder, Denis Bonnet, Eugene W. Schwilke, Marilyn A. Huestis, Catherine Ortemann-Renon, David A. Gorelick, David M. Schwope, Robert S. Goodwin
Publikováno v:
The American Journal on Addictions. 22:510-514
Background and Objectives Δ9-tetrahydrocannabinol (THC) promotes sleep in animals; clinical use of THC is associated with somnolence. Human laboratory studies of oral THC have not shown consistent effects on sleep. We prospectively evaluated self-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17f5dd768a66ba09bb15ed676e6df841
https://doi.org/10.1111/j.1521-0391.2013.12003.x
https://doi.org/10.1111/j.1521-0391.2013.12003.x
Autor:
Gerard Le Fur, Kenzie L. Preston, Marilyn A. Huestis, Stephen J. Heishman, Denis Bonnet, Susan J. Boyd, David A. Gorelick
Publikováno v:
Psychopharmacology. 194:505-515
A single 90-mg dose of the cannabinoid CB1 receptor antagonist rimonabant attenuates effects of smoked cannabis in humans.The objective of this study is to evaluate whether repeated daily 40-mg doses of rimonabant can attenuate effects of smoked cann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8b1f54627055a844ca9627b1d0be75
https://doi.org/10.1007/s00213-007-0861-5
https://doi.org/10.1007/s00213-007-0861-5
Autor:
Henri Chabrol, Denis Bonnet
Publikováno v:
Journal of Child and Adolescent Psychopharmacology. 5:107-113
In order to reduce the possible confounding effect of suicidality on studies of biological markers in adolescents, we examined a sample consisting solely of adolescents hospitalized following a suicide attempt. Of 112 adolescents hospitalized after a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a7b29d11b8eb1bf468207cdb9b511d
https://doi.org/10.1089/cap.1995.5.107
https://doi.org/10.1089/cap.1995.5.107
Autor:
Catherine Ortemann-Renon, Deanna L. Kelly, Robert P. McMahon, David M. Schwope, David A. Gorelick, Marilyn A. Huestis, Eugene W. Schwilke, Fang Liu, Denis Bonnet, William D. Darwin, Robert S. Goodwin
Oral cannabinoids are taken for medicinal or recreational purposes, yet little is known about tolerance to their effects after high-dose extended exposure. The development of tolerance to effects of around-the-clock oral synthetic Δ9-tetrahydrocanna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d833d34561f48a3b3e936ce7c3ceac
https://europepmc.org/articles/PMC3584989/
https://europepmc.org/articles/PMC3584989/
Autor:
David A, Gorelick, Robert S, Goodwin, Eugene, Schwilke, Jennifer R, Schroeder, David M, Schwope, Deanna L, Kelly, Catherine, Ortemann-Renon, Denis, Bonnet, Marilyn A, Huestis
Publikováno v:
The American journal on addictions. 22(5)
Δ9-tetrahydrocannabinol (THC) promotes sleep in animals; clinical use of THC is associated with somnolence. Human laboratory studies of oral THC have not shown consistent effects on sleep. We prospectively evaluated self-reported sleep parameters du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::263e1b6199b3695bb2b74fb1943af6ce
https://pubmed.ncbi.nlm.nih.gov/23952899
https://pubmed.ncbi.nlm.nih.gov/23952899
Autor:
Robert S. Goodwin, Eugene W. Schwilke, Marilyn A. Huestis, Fang Liu, William D. Darwin, Catherine Ortemann-Renon, David M. Schwope, David A. Gorelick, Robert P. McMahon, Denis Bonnet, Deanna L. Kelly
Publikováno v:
Journal of clinical psychopharmacology. 31(5)
Cannabinoid CB1 receptor antagonists have potential therapeutic benefits, but antagonist-elicited cannabis withdrawal has not been reported in humans. Ten male daily cannabis smokers received 8 days of increasingly frequent 20-mg oral Δ⁹-tetrahydr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bc7cc43712ac570a090f03f4a1738ab
https://pubmed.ncbi.nlm.nih.gov/21869692
https://pubmed.ncbi.nlm.nih.gov/21869692
Autor:
Jennifer R. Schroeder, Eugene W. Schwilke, William D. Darwin, Robert S. Goodwin, Marilyn A. Huestis, David A. Gorelick, Denis Bonnet, Deanna L. Kelly, Michael H. Baumann, Catherine Ortemann-Renon, David M. Schwope
The endocannabinoid system modulates the hypothalamic-pituitary-adrenal (HPA) axis, but the effect of cannabinoid type 1 (CB1) receptor antagonism following chronic CB1 receptor stimulation in humans is unknown.To evaluate effects of the CB1 receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f94075398a4f60337919b40412366f69
https://europepmc.org/articles/PMC3717353/
https://europepmc.org/articles/PMC3717353/
Autor:
Denis Bonnet, Henri Chabrol
Publikováno v:
The American journal of psychiatry. 153(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a59b66374d9f9de71ea21b74cf77b420
https://pubmed.ncbi.nlm.nih.gov/7793434
https://pubmed.ncbi.nlm.nih.gov/7793434